Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

Drug Highlight

Exenatide: A Novel Incretin Mimetic Agent for Treating Type 2 Diabetes Mellitus

Lam, Sum PharmD, CGP*†; See, Sharon PharmD, BCPS*‡

Author Information
doi: 10.1097/01.crd.0000223655.16253.e4
  • Buy

Abstract

© 2006 Lippincott Williams & Wilkins, Inc.